Munoz 1779

SPRINGFIELD – Biomarker testing — the medical technology used to determine medical risk factors like cancer — would be covered under state-regulated insurance plans under a measure sponsored by Assistant Majority Leader Tony (D-Chicago), which passed the Senate Tuesday.

“Inequalities exist in our health care services, especially for communities of color and people with lower income,” Munoz said. “Everyone deserves the right to benefit from this testing that can lead to better health outcomes, and this is essential for our fight against inequalities in our health care services.”

A “biomarker” is a sign of disease or abnormal function that can be measured in blood, tissue or bodily fluid. In cancer care, biomarkers are often used to help determine the best treatment for a patient. Biomarker testing analyzes a patient’s tissue, blood or other biospecimen for the presence of a biomarker.

Insurance coverage for biomarker testing is currently limited and disparate, a fact Munoz said leads to inequities in care for cancer patients.

House Bill 1779 requires group and individual accident and health insurance policies and managed care plans to include coverage for biomarker testing for the purposes of diagnosis and treatment.

“Figuring out the right treatment at the right time is going to improve the quality of life for patients at a lower cost,” Munoz said. “It’s necessary to give all patients access to these medical advancements, no matter their income level.”

House Bill 1779 passed the Senate with a vote of 58-0.

MunozSPRINGFIELD – Biomarker testing — the medical technology used to determine medical risk factors like cancer — would be required coverage under state-regulated insurance plans under a measure sponsored by Assistant Majority Leader Tony (D-Chicago), which was approved by the Senate Insurance Committee Wednesday.

“Many communities of color and people with lower income are less likely to have insurance plans that offer biomarker testing,” Munoz said. “We need to ensure that these medical advancements are not just for the rich and privileged. Everyone should be able to benefit from this technology.”

A “biomarker” is a sign of disease or abnormal function that can be measured in blood, tissue or bodily fluid. In cancer care, biomarkers are often used to help determine the best treatment for a patient. Biomarker testing analyzes a patient’s tissue, blood or other biospecimen for the presence of a biomarker.

Insurance coverage for biomarker testing is currently limited and disparate, a fact Munoz said leads to inequities in care for cancer patients.

House Bill 1779 requires group and individual accident and health insurance policies and managed care plans to include coverage for biomarker testing for the purposes of diagnosis and treatment.

“This legislation is going to lead to better health outcomes, an improved quality of life, and lower costs for the patients who most need this kind of care,” Munoz said. “It’s key to reducing health disparities for all patients, especially for lower income people.”

House Bill 1779 passed the Senate Insurance Committee and now heads to the Senate floor for further consideration.

MunozSPRINGFIELD – To pay tribute to fallen officers and their families, Assistant Majority Leader Tony Munoz (D-Chicago), a former Chicago Police Officer himself, attended the Illinois State Police Officers Memorial Ceremony in Springfield Thursday.

“This ceremony commemorates those who risk their lives every day to keep us safe and protect our communities,” Munoz said. “It is a time to honor the bravery of our fallen soldiers and show the surviving families that we support and care for them.”

Read more ...

Munoz Scool DistrictCHICAGO – Assistant Majority Leader Tony Munoz (D-Chicago) is announcing that Chicago Public Schools will receive $2.585 billion in additional funding to help address the many challenges presented by the COVID-19 pandemic.

“I would like to thank the local teachers, parents, and students for their hard work as this has been a difficult year for all,” Munoz said. “I’m confident this funding will help our students and schools move forward as the end of the pandemic is in sight.”

The funding comes as part of the two most recent federal COVID-19 relief packages. Schools, students and parents have overcome challenges that no one could have imagined before the pandemic began, including remote and hybrid learning, digital connection issues, new processes for receiving state and federal aid that normally flow through schools, and more.

Read more ...

COVID19 Updates

Newsletter Sign-up
  1. First Name(*)
    Invalid Input
  2. Last Name(*)
    Invalid Input
  3. Your Email(*)
    Please let us know your email address.

Contact Info

Springfield Office:
323A State Capitol Bldg.
Springfield, IL 62706
(217) 782-9415

Chicago Office:
1836 W. 35th St. 1st Fl.
Chicago, IL 60609
(773) 869-9050